Trial Shows CAR-T Cells May Be Effective in Treating Brain, Spinal Cord Lymphoma
Lymphoma usually starts in the spinal cord or brain, although sometimes tumors can spread to these sites from other regions in the body. This cancer is usually difficult to treat, particularly once the tumors don’t respond to the standard treatments. In such cases, patients do not live longer than a couple of years. Investigators at Dana-Farber Cancer Institute have found that a new CAR-T cell therapy may be effective in the treatment of lymphoma of the brain and/or spinal cord. They discovered that the axi-cel (axicabtagene ciloleucel) therapy could be safely administered to patients with the above indication. They presented…